Cellura Heads to Boston for Cell & Gene Therapy International 2026 From September 22 to 25, 2026, Cellura will attend Cell & Gene Therapy International 2026 (CGTI) at the Hynes…
A New Generation of Engineered Immune Cells CAR-T cell therapy has transformed the treatment of several hematological malignancies, but its clinical deployment remains constrained by patient-specific manufacturing, treatment delays, allogeneic…
The search for reliable biomarkers is becoming increasingly central to biomedical research. In oncology and precision medicine, biomarkers can support earlier disease detection, patient stratification, prognosis, treatment selection, and longitudinal…
